Ono Pharmaceutical Co., Ltd.

Ono Pharmaceutical Co., Ltd.

Ono Pharmaceutical Co., Ltd.

Overview
Date Founded

1947

Headquarters

1-8-2 Kyutaromachi,Chuo-Ku,Osaka 541-8564

Type of Company

Public

Employees (Worldwide)

3,607

Industries

Pharmaceuticals
Medical Support Services
Hospitals & Patient Services

Company Description

Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan.

Executives & Employees

President & Chief Executive Officer

Corporate Executive Officer, Executive Director, Corporate Regulatory Compliance, Safety & Quality Assurance

Corporate Officer, Senior Director, Medical External Affairs

Director, Executive Officer/Executive Director, Corporate Strategy & Planning

Corporate Executive Officer, Executive Director, Clinical Development

Director, Executive Officer/Executive Director, Discovery & Research

Managing Executive Officer, Director of Public Relations

Managing Executive Officer, Manager of Business Investigation Office, Director

Senior Partner

Senior Partner

Board of Directors

Managing Executive Officer, Manager of Business Investigation Office, Director at Ono Pharmaceutical Co., Ltd.

President & Chief Executive Officer at Ono Pharmaceutical Co., Ltd.

Director, Executive Officer/Executive Director, Discovery & Research at Ono Pharmaceutical Co., Ltd.

Corporate Executive Officer, Executive Director, Clinical Development at Ono Pharmaceutical Co., Ltd.

Director, Executive Officer/Executive Director, Corporate Strategy & Planning at Ono Pharmaceutical Co., Ltd.

Former Executive Officer at Iwatani Corp.

Outside Director at Ono Pharmaceutical Co., Ltd.

Paths to Ono Pharmaceutical Co., Ltd.
Potential Connections via
Relationship Science
You
Ono Pharmaceutical Co., Ltd.
Owners & Shareholders
Details Hidden

Wellington Management Japan Pte Ltd., a subsidiary of Wellington Management Group LLP, is a Japanese company located in Tokyo that provides investment advice. It was founded in 1997. Toshinori Hisamune is currently the CEO of the firm.

Details Hidden

Scott Investment Partners LLP is a British private company located in Henley-on-Thames that provides investment advice. The firm was founded in 2012 by Walter Grant Scott and Matthew Walter Thomas Scott. Walter Grant Scott has been the CEO since then.

Details Hidden

HQ Trust GmbH is a private company headquartered in Bad Homburg v. d. Höhe, Germany, that provides investment advice. Jochen Butz is the CEO, in this role since 2011.

Clients

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

Bristol-Myers Squibb Company Our company has a strong legacy of innovation that began in New York in 1858 when Edward R. Squibb, M.D., founded a pharmaceutical company in Brooklyn, and in 1887 when two friends, William McLaren Bristol and John Ripley Myers purchased a struggling drug manufacturing firm in Clinton. Together, they laid the foundation for our company today — a global BioPharma leader that continues this legacy of innovation.

Since 1987, Gilead Sciences has worked to discover, develop and commercialize medications to advance the care of patients suffering from life-threatening diseases in areas of unmet medical need. In 25 years, Gilead has become a leading biopharmaceutical company with a portfolio of 15 marketed products, a growing pipeline of investigational drugs and approximately 5,000 employees in offices across four continents. Gilead's therapeutic areas of focus include HIV/AIDS, hepatitis, serious respiratory, cardiovascular, and metabolic conditions, cancer and inflammation

Key Stats and Financials As of 2021
Market Capitalization
$11B
Total Enterprise Value
$12.2B
Earnings Per Share
$1.37
EBITDAMargin
34.89%
Enterprise Value / Sales
4.37x
Enterprise Value EBITDAOperating
12.53x
TEVNet Income
17.93x
Debt TEV
0.01x
Revenue
$2.8B
Three Year Compounded Annual Growth Rate Of Revenue
5.71%
Net Profit
$683M
EBITDA
$977M
Total Debt
$81.9M
Total Equity
$5.8B
Investments
Details Hidden

Rehab For JAPAN KK is a company headquartered in Tokyo, Japan. The firm provides software as a service type cloud support services for nursing care establishments. It was founded in 2016 by Ryo Okubo, he has been the CEO since the inception date.

Suppliers
Amgen, Inc. Hospitals & Patient Services | Thousand Oaks, CA

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Bausch Health Cos., Inc. Wholesale: Consumer Non-Durables/Sundries | Laval, Canada

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Salix segment consists of sales in the U.S. of GI products. The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.

Merck & Co., Inc. Medical Support Services | Kenilworth, NJ

Merck & Co., Inc., d.b.a. Merck Sharp & Dohme (MSD) outside the United States and Canada, is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668. Merck & Co. was established as an American affiliate in 1891.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Ono Pharmaceutical Co., Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Ono Pharmaceutical Co., Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Ono Pharmaceutical Co., Ltd..